High BNP level as risk factor for acute kidney injury and predictor of all-cause mortality in STEMI patients
Herz, cilt.39, sa.4, ss.507-514, 2014 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 39 Sayı: 4
- Basım Tarihi: 2014
- Doi Numarası: 10.1007/s00059-013-3853-8
- Dergi Adı: Herz
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.507-514
- Anahtar Kelimeler: ST-segment elevation myocardial infarction, Primary angioplasty, BNP, Mortality, Acute kidney injury
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Objectives. The aim of this study was to evaluate the predictive value of brain natriuretic peptide (BNP) in the development of acute kidney injury (AKI) and 6-month all-cause mortality after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in a modest-risk population. Background. The prognostic value of BNP has been well documented in patients with acute coronary syndrome. However, its value in development of AKI and 6-month all-cause mortality in patients with STEMI undergoing primary PCI remains unclear. Methods. We prospectively enrolled 424 consecutive STEMI patients (mean age 53.6±12.1 years) undergoing primary PCI. The population was divided into two groups: a high (n=110) and a low (n=314) admission BNP group according to the cut-off value (>88.7 pg/ml) determined by ROC analysis to have the best predictive accuracy for 6-month all-cause mortality. The clinical characteristics as well as the in-hospital and 6-month outcomes of patients undergoing primary PCI were analyzed. Results. Cox multivariate analysis showed that a high-admission BNP value (>88.7 pg/ml) was an independent predictor of AKI development (odds ratio, 1.002; 95% confidence interval, 1.000-1.003; p=0.02) and 6-month all-cause mortality (odds ratio, 1.003; 95% confidence interval; 1.001-1.004; p=0.004). Conclusion. These results suggest that a high-admission BNP level is associated with an increased risk of AKI development and 6-month all-cause mortality in patients with STEMI undergoing primary PCI. © 2013 Urban & Vogel.